These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8306317)

  • 1. Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression.
    Kim TM; Benedict WF; Xu HJ; Hu SX; Gosewehr J; Velicescu M; Yin E; Zheng J; D'Ablaing G; Dubeau L
    Cancer Res; 1994 Feb; 54(3):605-9. PubMed ID: 8306317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
    Dodson MK; Cliby WA; Xu HJ; DeLacey KA; Hu SX; Keeney GL; Li J; Podratz KC; Jenkins RB; Benedict WF
    Cancer Res; 1994 Feb; 54(3):610-3. PubMed ID: 8306318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoblastoma protein expression in ovarian epithelial neoplasms.
    Niemann TH; Trgovac TL; McGaughy VR; Lewandowski GS; Copeland LJ
    Gynecol Oncol; 1998 Jun; 69(3):214-9. PubMed ID: 9648590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma.
    Zhang X; Xu HJ; Murakami Y; Sachse R; Yashima K; Hirohashi S; Hu SX; Benedict WF; Sekiya T
    Cancer Res; 1994 Aug; 54(15):4177-82. PubMed ID: 8033150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologically benign or low-grade malignant tumors adjacent to high-grade ovarian carcinomas contain molecular characteristics of high-grade carcinomas.
    Zheng J; Wan M; Zweizig S; Velicescu M; Yu MC; Dubeau L
    Cancer Res; 1993 Sep; 53(18):4138-42. PubMed ID: 8364906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The retinoblastoma gene is involved in malignant progression of astrocytomas.
    Henson JW; Schnitker BL; Correa KM; von Deimling A; Fassbender F; Xu HJ; Benedict WF; Yandell DW; Louis DN
    Ann Neurol; 1994 Nov; 36(5):714-21. PubMed ID: 7979217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
    Ishikawa J; Xu HJ; Hu SX; Yandell DW; Maeda S; Kamidono S; Benedict WF; Takahashi R
    Cancer Res; 1991 Oct; 51(20):5736-43. PubMed ID: 1913692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
    Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
    Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and HER-2/neu gene amplification.
    Zheng JP; Robinson WR; Ehlen T; Yu MC; Dubeau L
    Cancer Res; 1991 Aug; 51(15):4045-51. PubMed ID: 1677312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression.
    Borg A; Zhang QX; Alm P; Olsson H; Sellberg G
    Cancer Res; 1992 May; 52(10):2991-4. PubMed ID: 1581913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expression of the retinoblastoma gene in ovarian neoplasms and correlation to p53 and K-ras mutations.
    Taylor RR; Linnoila RI; Gerardts J; Teneriello MG; Nash JD; Park RC; Birrer MJ
    Gynecol Oncol; 1995 Sep; 58(3):307-11. PubMed ID: 7545631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas.
    Simpson DJ; Magnay J; Bicknell JE; Barkan AL; McNicol AM; Clayton RN; Farrell WE
    Cancer Res; 1999 Apr; 59(7):1562-6. PubMed ID: 10197629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human epithelial ovarian cancer allelotype.
    Cliby W; Ritland S; Hartmann L; Dodson M; Halling KC; Keeney G; Podratz KC; Jenkins RB
    Cancer Res; 1993 May; 53(10 Suppl):2393-8. PubMed ID: 8485726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic deletion on chromosome 17p13.3 in early ovarian cancer.
    Phillips NJ; Ziegler MR; Radford DM; Fair KL; Steinbrueck T; Xynos FP; Donis-Keller H
    Cancer Res; 1996 Feb; 56(3):606-11. PubMed ID: 8564979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas.
    Edelson MI; Scherer SW; Tsui LC; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Oncogene; 1997 Jun; 14(24):2979-84. PubMed ID: 9205105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors.
    Wertheim I; Tangir J; Muto MG; Welch WR; Berkowitz RS; Chen WY; Mok SC
    Oncogene; 1996 May; 12(10):2147-53. PubMed ID: 8668340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers.
    Boynton RF; Huang Y; Blount PL; Reid BJ; Raskind WH; Haggitt RC; Newkirk C; Resau JH; Yin J; McDaniel T; Meltzer SJ
    Cancer Res; 1991 Oct; 51(20):5766-9. PubMed ID: 1913694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
    Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
    Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.
    Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC
    Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.